These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30509755)

  • 1. Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.
    Hidalgo-Lopez JE; Higa MG; Ferrian S; Lin P; Blando J; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2019 Jun; 40():174-175. PubMed ID: 30509755
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma--an analysis from the Austrian Myeloma Registry.
    Willenbacher W; Willenbacher E; Zelle-Rieser C; Biedermann R; Weger R; Jöhrer K; Brunner A
    Leuk Lymphoma; 2016; 57(6):1478-81. PubMed ID: 26413883
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma.
    Noonan KA; Huff CA; Davis J; Lemas MV; Fiorino S; Bitzan J; Ferguson A; Emerling A; Luznik L; Matsui W; Powell J; Fuchs E; Rosner GL; Epstein C; Rudraraju L; Ambinder RF; Jones RJ; Pardoll D; Borrello I
    Sci Transl Med; 2015 May; 7(288):288ra78. PubMed ID: 25995224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
    Leone P; Berardi S; Frassanito MA; Ria R; De Re V; Cicco S; Battaglia S; Ditonno P; Dammacco F; Vacca A; Racanelli V
    Blood; 2015 Sep; 126(12):1443-51. PubMed ID: 26185130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 Blockade Reinvigorates Bone Marrow CD8
    Kwon M; Kim CG; Lee H; Cho H; Kim Y; Lee EC; Choi SJ; Park J; Seo IH; Bogen B; Song IC; Jo DY; Kim JS; Park SH; Choi I; Choi YS; Shin EC
    Clin Cancer Res; 2020 Apr; 26(7):1644-1655. PubMed ID: 31941832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden.
    Goodyear O; Piper K; Khan N; Starczynski J; Mahendra P; Pratt G; Moss P
    Blood; 2005 Dec; 106(13):4217-24. PubMed ID: 16144804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma escape from immunity: an "inside" job.
    Rapoport AP
    Blood; 2015 Sep; 126(12):1401-3. PubMed ID: 26384282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.
    Fukunaga A; Miyamoto M; Cho Y; Murakami S; Kawarada Y; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Morikawa T; Okushiba S; Kondo S; Katoh H
    Pancreas; 2004 Jan; 28(1):e26-31. PubMed ID: 14707745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Infiltrating Lymphocytes in Breast Cancer. Association with Clinical and Pathological Parameters.
    Zabotina TN; Korotkova OV; Chertkova AI; Zakharova EN; Tabakov DV; Dzhgamadze NT; Savostikova MV; Artamonova EV; Khailenko VA; Kovalenko EI; Kadagidze ZG
    Bull Exp Biol Med; 2018 Dec; 166(2):241-244. PubMed ID: 30488197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.
    Noonan K; Marchionni L; Anderson J; Pardoll D; Roodman GD; Borrello I
    Blood; 2010 Nov; 116(18):3554-63. PubMed ID: 20664052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
    Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL
    J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
    Zelle-Rieser C; Thangavadivel S; Biedermann R; Brunner A; Stoitzner P; Willenbacher E; Greil R; Jöhrer K
    J Hematol Oncol; 2016 Nov; 9(1):116. PubMed ID: 27809856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
    Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
    Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
    Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
    Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.